Lowry S F
Department of Surgery, Cornell University Medical College, New York, NY.
Arch Surg. 1993 Nov;128(11):1235-41. doi: 10.1001/archsurg.1993.01420230063010.
The remarkable advances in molecular and cell biology occurring over the past four decades have served the cause of surgical science well. Our understanding of basic disease mechanisms and insights into potential new therapeutic strategies have occurred at a staggering pace. Perhaps nowhere in surgical biology are these mechanistic insights and therapeutic prospects more evident than in research defining the cytokine mediators of inflammation, injury, and repair. These proteins are secreted to some degree by virtually all immune cell types as well as by a diverse array of other nucleated cells, and their functions encompass a regulatory role on and among many components of the immune system. Such intense interest is well deserved because abnormalities or dysregulation of tissue and wound repair as well as of natural (innate) or specific (acquired) immune function underlie much of the morbidity and mortality associated with surgical practice. Indeed, it is evident that the insights gained from the study of such inflammatory mediators cross virtually every specialty of surgery, from the acute sequelae of severe injury and invasive infection to the chronic manifestations of benign and malignant processes.
在过去四十年中,分子和细胞生物学取得了显著进展,这对外科科学的发展起到了很好的推动作用。我们对基本疾病机制的理解以及对潜在新治疗策略的认识都以惊人的速度在发展。在外科生物学领域,这些机制性见解和治疗前景或许在定义炎症、损伤和修复的细胞因子介质的研究中最为明显。几乎所有免疫细胞类型以及各种其他有核细胞都会在一定程度上分泌这些蛋白质,它们的功能涵盖了对免疫系统许多组成部分的调节作用。这种浓厚的兴趣是当之无愧的,因为组织和伤口修复以及天然(固有)或特异性(后天获得)免疫功能的异常或失调是外科实践中许多发病和死亡情况的基础。事实上,很明显,从对这类炎症介质的研究中获得的见解几乎涉及外科的各个专业领域,从严重损伤和侵袭性感染的急性后遗症到良性和恶性疾病的慢性表现。